Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05172011 · ClinicalTrials.gov registry record

Understanding the Long-term Impact of COVID on Children and Families

A clinical trial of SARS CoV 2 Infection, sponsored by NYU Langone Health.

Active
Registry status
15,028
Enrollment target
20
Study locations

NCT05172011 is a study of SARS CoV 2 Infection that is active but no longer recruiting, run by NYU Langone Health. The registered enrollment target is 15,028 participants, above the 4,429-participant average among 28 other SARS CoV 2 Infection trials with a reported enrollment target (239% higher). The trial reports 20 study locations across 11 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05172011, a study of SARS CoV 2 Infection, is active but no longer recruiting, sponsored by NYU Langone Health.

ACTIVE NOT RECRUITING
Registry status
15,028 participants
Enrollment target
20
Study locations

Study Summary

This is a combined retrospective and prospective, longitudinal, observational meta-cohort of individuals age 0-25 years who will enter the cohort with and without SARS-CoV-2 infection at varying stages before and after infection. Individuals with and without SARS-CoV-2 infection and with or without PASC symptoms will be followed to identify risk factors and occurrence of PASC. This study will be conducted in the United States and participants will be recruited through inpatient, outpatient, and community-based settings. Study data including age, demographics, social determinants of health, medical history, vaccination history, details of acute SARS-CoV-2 infection, overall health and physical function, and PASC symptoms will be reported by participants or collected from the electronic health record using a case report form at specified intervals. Biologic specimens will be collected at specified intervals, with some tests performed in local clinical laboratories and others performed by centralized research centers or banked in the Biospecimen Repository. Advanced clinical examinations and radiologic examinations will be performed at local study sites with cross-site standardization.

Conditions Studied

SARS CoV 2 Infection

Study Locations (20)

California

  • University of California San Diego - La Jolla
  • Children's Hospital Los Angeles - Los Angeles
  • University of California San Diego Health - Rady Children's Hospital - San Diego
  • University of California San Francisco (Pregnancy Cohort) - San Francisco
  • University of California San Francisco - San Francisco

Illinois

  • Northwestern University - Evanston
  • Northshore University HealthSystem - Glenview
  • American Academy of Pediatrics - Itasca

Connecticut

  • Connecticut Children's Medical Center - Hartford
  • Yale School of Medicine (YSM) - New Haven

Delaware

  • ChristianaCare Health System - Newark
  • Nemours Children's Health - Wilmington

Louisiana

  • Louisiana State University (LSU) - Pennington Biomedical Research Center - Baton Rouge
  • Tulane University - New Orleans

Alabama

  • University of Alabama at Birmingham (Pregnancy Cohort) - Birmingham

Arkansas

  • Arkansas Children's Hospital and Research Institute - Little Rock

District of Columbia

  • George Washington University - Washington D.C.

Trial Details

FieldValue
Enrollment Target 15,028 participants
Start Date 2022-03-01
Est. Completion 2027-05-23

Sponsor

NYU Langone Health

1,164 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT05172011

The ClinicalTrials.gov registry entry for NCT05172011 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 15,028 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 4,429-participant average among 28 other SARS CoV 2 Infection trials with a reported enrollment target (239% higher). The listed sponsor is NYU Langone Health, which has 1,164 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with SARS CoV 2 Infection appearing as the primary indexed condition, and to 0 interventions.

NCT05172011 reports 20 study locations spanning 11 distinct geographic areas - top geographies include California, Illinois, Connecticut.

Frequently Asked Questions

What is clinical trial NCT05172011 about?

NCT05172011 is a clinical study titled "Understanding the Long-term Impact of COVID on Children and Families". This is a combined retrospective and prospective, longitudinal, observational meta-cohort of individuals age 0-25 years who will enter the cohort with and without SARS-CoV-2 infection at varying stages before and after infection. Individuals with and without SARS-CoV-2 infection and with or without ...

What is the current status of trial NCT05172011?

This trial is currently active not recruiting. The enrollment target is 15,028 participants. The study started on 2022-03-01. Estimated completion is 2027-05-23.

What conditions does trial NCT05172011 study?

This clinical trial studies the following conditions: SARS CoV 2 Infection.

Who is sponsoring clinical trial NCT05172011?

This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05172011 being conducted?

This trial has 20 study locations across Alabama, Arkansas, California, Connecticut, Delaware. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for SARS CoV 2 Infection

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

SARS CoV 2 Infection

All registered trials for this condition

Alabama

All trials with a study site in Alabama

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.